Anaemia in cancer patients: Advances and challenges in the era of precision oncology
Authors:
Top Cited Papers
Open Access
- 2 June 2025
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 213, 104788
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Safety profile of trastuzumab deruxtecan in advanced breast cancer: Expert opinion on adverse event managementClinical and Translational Oncology, 2024
- Treatment‐related adverse events of antibody–drug conjugates in clinical trials: A systematic review and meta‐analysisCancer, 2022
- 58O Safety interim analysis (SIA) of the phase III postneoadjuvant SASCIA study evaluating sacituzumab govitecan (SG) in patients with primary HER2-negative breast cancer (BC) at high relapse risk after neoadjuvant treatmentAnnals of Oncology, 2022
- Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapyAnnals of Oncology, 2021
- Supplementation with Sucrosomial® iron leads to favourable changes in the intestinal microbiome when compared to ferrous sulfate in miceBioMetals, 2021
- A multi-centre case series of alectinib-related erythrocyte membrane changes and associated haemolysisJournal of Hematopathology, 2021
- Clinical toxicity of antibody drug conjugates: a meta-analysis of payloadsInvestigational New Drugs, 2017
- Diagnosis and treatment of cancer‐related anemiaAmerican Journal of Hematology, 2014
- Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated AnemiaJAMA, 2008
- Anaemia-related impairment in quality of life in elderly cancer patients prior to chemotherapyJournal of Cancer Research and Clinical Oncology, 2006